1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Sonic Healthcare Limited
  6. News
  7. Sector news
    SHL   AU000000SHL7

SONIC HEALTHCARE LIMITED

(SHL)
  Report
Delayed Australian Stock Exchange  -  02:10 2022-08-15 am EDT
33.64 AUD   +0.15%
08/08Proteomics International Signs Deal for Potential Distribution of Kidney Disease Test PromarkerD in US; Shares Rally 11%
MT
06/20SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
06/15SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Medical & Diagnostic Laboratories
08/12SYNLAB : Deutsche Bank reiterates its Buy rating
MD
08/11SYNLAB AG Reports Earnings Results for the Half Year Ended June 30, 2022
CI
08/11SYNLAB : JP Morgan sticks Neutral
MD
08/11TRANSCRIPT : SYNLAB AG, Q2 2022 Earnings Call, Aug 11, 2022
CI
08/11SYNLAB AG Revises Earnings Guidance for the Fiscal Year 2022
CI
08/03UnitedHealth struggling to sell Brazilian unit Amil - sources
RE
08/03EXCLUSIVE : UnitedHealth struggling to sell Brazilian unit Amil
RE
08/03UnitedHealth struggling to sell Brazilian unit Amil
RE
08/01UBS Adjusts Dr. Lal Pathlabs' Price Target to 2,700 Indian Rupees From 2,800 Rupees, Ke..
MT
07/29Dr. Lal PathLabs' Consolidated Net Profit Slides in Fiscal Q1; Shares Jump 6%
MT
07/28TRANSCRIPT : Dr. Lal PathLabs Limited, Q1 2023 Earnings Call, Jul 28, 2022
CI
07/28Dr. Lal Pathlabs Limited Declares an Interim Dividend for the Financial Year 2022-23, P..
CI
07/28Dr. Lal PathLabs Limited Reports Earnings Results for the First Quarter Ended June 30, ..
CI
07/26UBS Adjusts Dr. Lal Pathlabs' Price Target to 2,800 Indian Rupees From 3,700 Rupees, Ke..
MT
07/19SYNLAB : Buy rating from Barclays
MD
07/15SYNLAB : Deutsche Bank gives a Buy rating
MD
07/11SYNLAB : Jefferies reiterates its Buy rating
MD
06/30Dr. Lal Pathlabs Limited Declares Final Dividend for the Financial Year Ended March 31,..
CI
06/21SYNLAB : Gets a Neutral rating from JP Morgan
MD
06/21SYNLAB Seeks M&A
CI
06/21TRANSCRIPT : SYNLAB AG - Analyst/Investor Day
CI
06/09Dr. Lal Pathlabs Limited Proposes Final Dividend for the Financial Year Ended March 31,..
CI
06/08SYNLAB : Receives a Buy rating from Deutsche Bank
MD
05/31SYNLAB : Barclays maintains a Buy rating
MD
05/25SYNLAB : JP Morgan remains Neutral
MD
05/20Nomura Adjusts Dr. Lal Pathlabs' Price Target to 1,771 Indian Rupees From 2,465 Rupees,..
MT
05/17TRANSCRIPT : Dr. Lal PathLabs Limited, Q4 2022 Earnings Call, May 17, 2022
CI
05/17Dr. Lal Pathlabs Limited Proposes Final Dividend for the Year Ended March 31, 2022
CI
05/17Dr. Lal PathLabs Limited Reports Earnings Results for the Fourth Quarter and Full Year ..
CI
05/13TRANSCRIPT : Diagnósticos da América S.A., Q1 2022 Earnings Call, May 13, 2022
CI
05/13SYNLAB : Receives a Buy rating from Deutsche Bank
MD
05/13SYNLAB : JP Morgan sticks Neutral
MD
05/12SYNLAB : Barclays reiterates its Buy rating
MD
05/12TRANSCRIPT : SYNLAB AG, Q1 2022 Earnings Call, May 12, 2022
CI
05/12SYNLAB : Gets a Neutral rating from JP Morgan
MD
05/12SYNLAB : Jefferies reaffirms its Buy rating
MD
05/12SYNLAB AG Revises Earnings Guidance for 2022
CI
05/12Diagnósticos da América S.A. Reports Earnings Results for the First Quarter Ended March..
CI
05/12SYNLAB AG Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/02DIAGNÓSTICOS DA AMÉRICA S.A.(BOVESPA : DASA3) added to Brazil Mid-Large Cap Index
CI
05/01Certain Ordinary Bearer Shares of SYNLAB AG are subject to a Lock-Up Agreement Ending o..
CI
04/29UBS Adjusts Guangzhou Kingmed Diagnostics' Price Target to 97 Yuan From 100 Yuan, Keeps..
MT
04/26Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the First Qu..
CI
04/26Certain Ordinary Bearer Shares of SYNLAB AG are subject to a Lock-Up Agreement Ending o..
CI
04/20UBS Adjusts Guangzhou Kingmed Diagnostics' Price Target to 100 Yuan From 230 Yuan, Keep..
MT
04/11Fitch Confirms Synlab's BB Rating Citing Large, Stable European Operations
MT
04/11SYNLAB : Deutsche Bank reiterates its Buy rating
MD
04/07Moody's Upgrades Synlab Outlook To Positive, Affirms Long-Term Rating
MT
03/28Diagnósticos da América S.A. Reports Earnings Results for the Full Year Ended December ..
CI
03/24SYNLAB AG (DB : SYAB) announces an Equity Buyback for 660,566 shares, for €16.51 mill..
CI
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on SONIC HEALTHCARE LIMITED